There is also accumulating evidence that LRG1 has important angiocrine and angiopathic functions in cancer, not only by promoting the development of destabilized and immature neo-vessels, but also by impairing already established co-opted vasculature (Figure 3). The gene discussed is LRG1; the disease is cancer.